No Data
No Data
No Data
No Data
No Data
Trading in Allegra Medical Technologies' Stock Could Resume on March. 25
Trading in Allegra Medical Technologies' (ASX:AMT) shares, suspended on Feb. 23 following the firm's decision to defer the publication of its half-yearly results report, is expected to resume on March
MT NewswiresMar 11 07:46 ET
Allegra Medical Technologies Pulls Out of FDA Submission for Spinal Cage Device
Allegra Medical Technologies (ASX:AMT) withdrew its formal submission to the Food and Drug Administration for the Spinal Cage device. The biotechnology company cited the "need for additional supportin
MT NewswiresFeb 6 04:39 ET
Allegra Orthopaedics Files Informal Response to US FDA Request for Spinal Cage Implant Application
Allegra Orthopaedics (ASX:AMT) filed an informal response to the US Food and Drug Administration's request for additional information related to the biotechnology firm's application for the Sr-HT-Gahn
MT NewswiresDec 5, 2023 01:39 ET
Allegra Medical Technologies Completes Name Change
Allegra Medical Technologies (ASX:AMT) has changed its name from Allegra Orthopaedics following receipt of shareholder approval at its Nov. 1 annual general meeting. The name change process has been c
MT NewswiresNov 1, 2023 21:07 ET
Allegra Orthopaedics Establishes Submission Timeline for US FDA Request on Spinal Cage Application
Allegra Orthopaedics (ASX:AMT) established a submission timeline based on the request of the US Food and Drug Administration for its spinal cage device application. The medical device firm is now expe
MT NewswiresSep 29, 2023 01:18 ET
Allegra Orthopaedics (ASX:AMT) Submits Application for Spinal Cage Device Clearance
The Market HeraldMar 31, 2023 02:41 ET
No Data
No Data